Spanish Biotech Platform
Plataforma de Mercados Biotecnológicos
Iden Biotechnology
11/18/2013
WHITE WHITE
Iden Biotechnology S.L. (Spain) and Ingeniería Metabólica S.A. (INMET) (Argentina) sign commercial license and development agreement

The companies announce the signature of an agreement for the development and licensing of a technology that enables the recovery of the glycerol generated in the biodiesel production.
 
Pamplona (Spain) and Rosario (Argentina) (October 22, 2013) –

Iden Biotechnology S.L., a Spanish R&D company and the Argentinean company Ingeniería Metabólica (INMET), today announced that they have signed an agreement for the development and licensing of a technology that enables the recovery of the glycerol generated as byproduct in the biodiesel production.
This technology was developed by researchers of Conicet (Argentinean Scientific Council) in collaboration with Iden Biotechnology and has been the subject of a patent application by the Spanish company.
With this agreement, the aim is to optimize the technology and to obtain the license for South America by Inmet.

About Iden Biotechnology:
Iden Biotechnology brings basic research closer to the market through the establishment of strategic R&D collaboration agreements, the development of technical projects and the marketing of the derived knowledge and technologies globally. Iden Biotechnology product portfolio includes both IP protected technological solutions as well as integrated R&D services. Iden works with agri-biotech and microbiotech tools to develop innovative technologies for agriculture and sub-products valorisation. The company has financial support from SODENA (Navarra Development Society) and CRB Inverbío. More info at www.idenbiotechnology.com

About Inmet
Inmet S.A. is a pioneer company in Argentina that develops genetically optimized bacteria for the production of high commercial value compounds at the lowest environmental impact and from low cost materials. Inmet has implemented technological solutions that replace chemical products by biological ones, both sustainable and biodegradable. Inmet started in 2011, on an initiative of researchers from IBR-CONICET , and INDEAR. It promotes integration and collaborative work with private companies, universities, investigation institutes and the National government, to achieve economic development based on the knowledge derived from science and technology.
For further information: www.ingenieriametabolica.com.ar
 
 
 
 
Permalink: http://www.mercadosbiotecnologicos.com/?iid=96&own=2&itid=1&lan=en
 
Search